Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
for the AIDS Malignancy Consortium
Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
34
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Vorinostat
81%
Non-Hodgkin's Lymphoma
54%
HIV
39%
Human Herpesvirus 8
29%
Human Herpesvirus 4
22%
Plasmablastic Lymphoma
19%
Primary Effusion Lymphoma
17%
Burkitt Lymphoma
13%
Drug Therapy
13%
Histone Deacetylase Inhibitors
13%
Lymphoma, Large B-Cell, Diffuse
12%
Rituximab
12%
Vincristine
12%
Etoposide
12%
Prednisone
11%
Neutropenia
11%
Thrombocytopenia
10%
Cyclophosphamide
10%
Doxorubicin
10%
B-Lymphocytes
8%
Cell Death
8%
Therapeutics
7%
Survival
6%
Chemical Compounds
Vorinostat
100%
Prednisone
29%
Vincristine
28%
Cyclophosphamide
26%
Etoposide
26%
Histone
20%
Cell Death
20%
Doxorubicin
19%